Elad Kedar and Jeff Weinhuff Share the Recipe for Orasis Pharmaceuticals

OIS Podcast | Ophthalmology's leading Podcast

English - May 07, 2020 10:00 - 27 minutes - 18.7 MB - ★★★★★ - 30 ratings
Investing Business Health & Fitness ophthalmology investment venture capital entrepreneurs oftalmólogo ophthalmic key opinion leader seco ascrs aao Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Leadership - How to Measure & Motivate in a Startup Environment

Next Episode: Challenging Conventional Thinking with the Laws of Physics

Elad Kedar, CEO of Orasis Pharmaceuticals shares his strategy for successfully completing a Phase 2b clinical study in preparation of their phase 3 of CSF-1 drops for temporary correction of presbyopia. Jeff Weinhuff from Visionary Ventures joins the conversation as Chairman of the Board to explain how he evaluated the Orasis technology and what VCs look for.